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Abstract
Background: Population aging accompanied by an increased longevity with disability has raised international
concern, especially due to its costs to the health care systems. Chronic diseases are the main causes of physical
disability and their simultaneous occurrence in the population can impact the disablement process, resulting in
different severity levels. In this study, the contribution of chronic diseases to both mild and severe disability burden
in Belgium was investigated.
Methods: Data on 21 chronic diseases and disability from 35,799 individuals aged 15 years or older who
participated in the 1997, 2001, 2004, or 2008 Belgian Health Interview Surveys were analysed. Mild and severe
disability were defined based on questions related to six activities of daily living and/or mobility limitations. To
attribute disability by severity level to selected chronic diseases, multiple additive hazard models were fitted to each
disability outcome, separately for men and women.
Results: A stable prevalence of mild (5 %) and severe (2–3 %) disability was observed for the Belgian population
aged 15 years or older between 1997 and 2008. Arthritis was the most important contributor in women with mild
and severe disability. In men, low back pain and chronic respiratory diseases contributed most to the mild and
severe disability burden, respectively. The contribution also differed by age: for mild disability, depression and
chronic respiratory diseases were important contributors among young individuals, while heart attack had a large
contribution for older individuals. For severe disability, neurological diseases and stroke presented a large
contribution in young and elderly individuals, respectively.
Conclusions: Our results indicate that the assessment of the contribution of chronic diseases on disability is more
informative if different levels of disability are taken into consideration. The identification of diseases which are related to
different levels of disability – mild and severe – can assist policymakers in the definition and prioritisation of strategies
to tackle disability, involving prevention, rehabilitation programs, support services, and training for disabled individuals.
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Background
Information on disability is considered essential to under-
stand and respond to the global phenomenon of popu-
lation aging, especially due to its economic costs and
impact in the quality of life of individuals. Chronic dis-
eases are known to be the main cause of physical disa-
bility [1] and to reduce the autonomy of individuals in
performing basic activities of daily living (ADL) [2]. The
simultaneous occurrence of chronic diseases in individuals
can have a different impact in the disablement process,
resulting in different disability severity levels, which
ranges from difficulty to inability to perform a task
without assistance, i.e. dependence [3–7].
Several methods have been proposed to assess the
disability burden in a population. For cross-sectional
data, Nusselder and Looman recently proposed the attri-
bution method to assess the disability burden [8, 9]. This
method is based on multiple additive hazard models,
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which partition the disability prevalence into the additive
contribution of diseases and conditions in the presence
of comorbidity [9, 10].
Although the method has been widely used to assess
the disability burden in several countries [8, 10–16], to
our knowledge, the contribution of chronic diseases to
different disability severity levels was not yet investi-
gated. In our previous study, we determined the major
contributors of the disability burden without distinguish-
ing different disability severity levels in Belgium [16].
However, this distinction can be useful to assist policy
makers in the definition of strategies to reduce the
disability burden, as the assessment of dependence to
perform ADLs can predict institutionalization, the need
of home care services, and mortality [2, 6, 17].
The aim of this study was to assess the contribution of
selected chronic diseases to the mild and severe disabil-
ity burden in Belgium. Here, mild disability was consid-
ered a measure of difficulty in performing at least one
ADL or mobility task, while severe disability was consid-
ered a measurement of dependence – inability to per-
form at least one ADL without assistance – or severe
restriction in mobility.
Methods
Study population
The Belgian Health Interview Survey (BHIS) data from
1997, 2001, 2004, and 2008 were used in this analysis.
The BHIS is a national household survey, repeated every
3–5 years, commissioned by all the ministers responsible
for public health at the federal, regional, and community
levels in Belgium. It is conducted by the Scientific Ins-
titute of Public Health in collaboration with Statistics
Belgium [18]. A multistage sampling design with geo-
graphical stratification (regions and provinces) and clus-
tering (municipalities and households) was applied to
obtain a representative sample of the Belgian population,
including elderly individuals living in nursing homes and
homes for the elderly. Proxy interviews were mandatory
for individuals aged < 15 years and allowed for individ-
uals with severe mental or physical illness not able to
reply themselves, if the selected person was not reach-
able for more than 1 month, and for individuals who
refused to participate but allowed proxy answers. Each
survey included approximately 10,000 individuals. The
response rate was 59 % in 1997, 61 % in 2001, 61 % in
2004, and 55 % in 2008. Sampling weights were used to
take into account the complex sample design. The data
quality control was implemented in the fieldwork, data
entry, and statistical analysis [19]. More details about the
surveys methodology can be found elsewhere [18, 20].
This analysis was restricted to individuals aged 15 years
or older, as the disability questions were restricted to
this subpopulation. The selection of individuals included
in this study is presented in Fig. 1. Subjects with missing
information on disability or selected diseases (n = 3,788;
10 %) were excluded. In total, 35,799 individuals were
included in the analysis (Fig. 1).
Mild and severe disability
The definition of disability was based on self-reported
questions about ADL and mobility limitations included
in the face-to-face questionnaire in the four BHIS. For
mobility limitations, the question “What is the furthest
you can walk on your own without stopping and without
severe discomfort?” was analysed, with possible answers:
“a. Only a few steps”, “b. More than few steps, but less
than 200 m”, or “c. 200 m or more”.
Six ADLs were included in the disability indicator:
getting in and out of bed, getting in and out of chair,
dressing and undressing, washing hands and face, feed-
ing and cutting up food, and using the toilet. These
questions are part of the instrument to measure disabil-
ity proposed by the World Health Organization (WHO)
[21]. Although urinary incontinence is also included in
the set of questions recommended by the WHO [21], we
did not include it in our disability definition, as it may
exist without physical limitations and, therefore, it is no
longer considered as ADL disability [6].
In the 1997, 2001, and 2004 BHIS, the questions
“Can you … (ADL) on your own?”, with possible an-
swers “a. Yes, without difficulty”, “b. Yes, with some diffi-
culty”, “c. I only … (ADL) with someone to help me” were
analysed. In 2008, the format of the ADL questions
slightly changed, with one main question included before
the list of ADLs: “Do you usually have difficulty doing any
of these activities by yourself?” and one extra option of
answer was included: “a. No difficulty”, “b. Yes, some
difficulty”, “c. Yes, a lot of difficulty”, “d. I can’t achieve it
by myself”.
A person was considered mildly disabled if he/she
answered “b” to the mobility question or to at least one
ADL question; and severely disabled if the answer was
“a” to the mobility question or “c” to at least one ADL
question in 1997, 2001, and 2004, or “c” or “d” to at least
one ADL question in 2008.
As described above, the mild disability definition can
be considered a measure of difficulty while the severe
disability definition can be considered a measure of
dependence.
Chronic diseases
Data on self-reported chronic diseases in the year preceding
the interview were collected through a face-to-face inter-
view in the BHIS. In this analysis, 21 chronic diseases or
disease groups that were available in the four BHIS were in-
cluded: chronic respiratory diseases (asthma, chronic bron-
chitis, and chronic pulmonary diseases), diabetes, cancer,
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depression, chronic cystitis, heart attack, stroke, arthritis
(rheumatoid arthritis and osteoarthritis), low back pain,
osteoporosis, stomach ulcer, bowel diseases, liver diseases
(hepatitis, cirrhosis, and other liver dysfunctions), gall-
stones, cataract, glaucoma, migraine, thyroid problems, skin
diseases, chronic kidney diseases, and neurological diseases
(epilepsy and Parkinson’s disease).
Most of the diseases questions were not modified over
the four BHIS waves. The main changes occurred for
heart attack and low back pain. From 1997 to 2004, one
question was included for “serious heart disease or heart
attack”. However, in 2008, this question was split into
two: “myocardial infarction” and “coronary heart diseases
(angina pectoris)”. In this study, we grouped these two
diseases, i.e. an individual was considered to have had a
heart attack in the year preceding the interview if he/she
answered “Yes” to the question of “serious heart disease
or heart attack” in 1997–2004 or to at least to one of the
questions – “myocardial infarction” or “coronary heart
diseases (angina pectoris)” – in 2008.
In 1997, low back pain was described as “chronic spinal
affection for longer than 3 months”, while in 2001 and
2004 “lumbago, sciatica, and disc prolapse” was added to
the 1997 question. Nonetheless, in 2008, the question
changed to “low back disorder or other chronic back
defect”. The impact of the changes in the questions can
be observed in the disease prevalence by gender and
BHIS year, shown in the Additional file 1.
Statistical analysis
Age and gender standardized disability prevalence per
year using the direct standardization method [22] is
presented to assess the disability prevalence trend for
individuals aged 15 years or older in the study period.
The prevalence of disability by cause was estimated
using the attribution method [11]. In this method, dis-
ability is attributed to disease and “background”, taking
into account that individuals can have more than one
disease (comorbidity) and that disability can be present
in individuals without any disease [9]. For instance, even
if an individual reports a disease in the survey, this is
not necessarily the cause of the disability. This disability
that is not associated with the diseases included in the
analysis is labelled “background” [11].
The background may be a result of the disability that
is not associated with any disease, underreporting and
underdiagnosed diseases in the survey, disability causes
that occurred before the year preceding the interview
(for example, permanent consequences of accidents,
falls), and disability causes not included in the survey or
analysis [8–10].
BHIS – 1997
N = 10,221
BHIS – 2001
N = 12,111
BHIS – 2004
N = 12,945
BHIS – 2008
N = 11,254
Participants of the BHIS
Individuals aged ≥ 15 years
Pooled data of 1997, 2001, 2004, and 2008
N = 39,587 
BHIS – 1997
N = 8,560
BHIS – 2001
N = 10,156
BHIS – 2004
N = 11,220
BHIS – 2008
N = 9,651
Severe disability 
N = 2,352 (6%)
Complete disability data
N = 37,696 (95%)
Missing disability data
N = 1,891 (5%)
Not disabled
N = 31,939 (85%)
Missing disease
N = 1,268 (4%)
Complete disease
N = 30,671(96%)
Missing disease
N = 338 (10%)
Complete disease
N = 3,067 (90%)
Missing disease
N = 291 (12%)
Complete disease
N = 2,061(88%)
Mild disability 
N = 3,405 (9%)
Fig. 1 Description of the study sample. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008
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The main assumptions of the method are: the distribu-
tion of disability by cause is entirely explained by dis-
eases that are still present at the time of the survey and
by the background; the cause-specific disability rates for
each disease were proportionally equal in the time pre-
ceding the survey; individuals from the same age groups
are exposed to the same background rate; the causes of
disability (diseases and background) act as independent
competing causes; and the start of the time at risk for
disability is the same for all causes [9].
The attribution method is based on a multiple additive
hazards model [11], defined as shown in (1).
Yi∼BernoulliðπiÞ
πi ¼ 1−e−ηi
ηi ¼ αa þ
Xm
d¼1
βcd  Xdi
ð1Þ
Where Yi is the binary response (disability) variable for
each individual i; πi is the estimated probability that
individual i is disabled; e is the base of the natural loga-
rithm; ηi is the total disability rate (linear predictor) for
each individual i; αa is the background disability rate by
age group a(1, …, n); βcd is the disease-specific disability
rate (disabling impact); and Xdi is the indicator variable
for each disease d and individual i.
In model (1), the disease-specific disability rate is de-
fined as βcd = γc × δd, where γc is the age pattern, that
varies across age group c(1, …, k) but is constant across
diseases; and δd is the disease effect, which differs across
diseases, but not by age group. In other words, both the
background and the diseases are allowed to vary by age.
Hence, model (1) is a reduced rank regression (RRR)
model with one rank [23]. The attribution of disability to
chronic diseases and background depends on the disease
prevalence (Xdi) and on the disease-specific disability
rate (βcd) [10].
The total disability rate (ηi) is partitioned into back-
ground (αa) and disease-specific disability rates (βcd).
The probability of individual i to be disabled due to dis-
ease d is defined as Ddi ¼ βcdXdiηi  πi , i.e. the proportion
of the disease-specific disability rate (βcd × Xdi) in the
total disability rate (ηi) multiplied by the probability of
being disabled (πi); and the probability of individual i to
be disabled due to background is defined as Bi ¼ αaηi  πi ,
i.e. the proportion of the background disability rate (αa)
in the total disability rate (ηi) multiplied by the probability
of being disabled.
The total probability of being disabled for each indi-
vidual i is obtained by the sum of the cause-specific
probabilities of being disabled: Bi and Ddi. The total
number of disabled individuals by cause can be obtained
by the sum of the cause-specific probabilities for each
individual in the sample. The prevalence of disability by
cause is then obtained by dividing the number of dis-
abled individuals for each cause by the total number
individuals in the sample.
For each disability outcome (mild and severe disability)
separate models for men and women were fitted. The
confidence intervals for the disease prevalence, param-
eter estimates of the models (background and disease-
specific disability rates), and the prevalence of disability
by cause were estimated by 1000 bootstrap replicas sam-
pled with replacement of equal sample size as the ori-
ginal data [24].
The diseases that were not significant in the additive
hazards models for each disability outcome were grouped
as “other diseases” and included in the final models. The
following non-significant diseases were included in the
“other diseases” group: kidney diseases, liver diseases,
gall-stones, glaucoma, cataract, thyroid problems, skin
diseases, and migraine.
The multiple additive hazard models and the attribu-
tion of disability to chronic diseases were performed
with the software developed by Nusselder and Looman
[8, 9] in R, version 3.0.3 [25]. More details about the
attribution method can be found in previous publica-
tions [8, 9, 11].
Ethics
The surveys were carried out by Statistics Belgium within
the legal framework provided by the statistical law in
Belgium. Therefore, the project was exempted from sub-
mission to an ethical committee, but it had to be approved
by the High Statistical Council. The use of the data by
external researchers is possible upon authorisation from
the Belgian Privacy Commission.
Results
Characteristics of the study population
Table 1 shows detailed information of the study popu-
lation. A higher proportion of females, elderly (≥65 years),
and low educated (no diploma or primary school) indi-
viduals were observed among mildly and severely dis-
abled subjects compared to individuals without disability.
Proxy interviews represented 9 % of the total number of
interviews, reaching 29 % in the individuals with severe
disability. The hospitalization rate in the 2004 and 2008
BHIS was 12.5 %, with an increasing trend with disability
severity. Mobility limitation was the most frequent limi-
tation, with increasing proportion according to disability
severity level. For example, the proportion of mobility
limitation was 77 % in severely disabled individuals and
65 % in mildly disabled individuals. The most common
ADL limitations among individuals with mild disability
were transfer in and out of bed (39.8 %) and transfer in
and out of chair (35.5 %) while for severely disabled
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individuals, dressing and undressing (41.9 %) and transfer
in and out of bed (35.5 %) were the most frequent ADL
limitations.
Age and gender standardized disability prevalence
The age and gender standardized disability prevalence
was higher for mild disability than for severe disability
in the four BHIS (Fig. 2). However, no difference was
observed for mild and severe disability over time across
the four BHIS: the prevalence of mild disability varied
from 5.1 % (95 % CI = 4.4 %; 6.0 %) in 1997 to 5.0 % (95 %
CI = 4.3 %; 5.8 %) in 2008 and the prevalence of severe
disability was 1.9 % (95 % CI = 1.5 %; 2.4 %) in 1997 and
2.8 % (95 % CI = 2.3 %; 3.3 %) in 2008 (Fig. 2).
Disease prevalence
The attribution of disability to diseases and background
is a function of two components: the disease prevalence
and disease-specific disability rate. In general, the preva-
lence of chronic diseases was higher in individuals with
mild or severe disability compared to non-disabled indi-
viduals (Tables 2 and 3). Arthritis and back pain were
among the most prevalent diseases in men and women
across all age groups and disability severity levels.
Table 1 Characteristics of the study participants. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008
Characteristic Total Not disabled Mild disability Severe disability
N %a N %a N %a N %a
Gender (female)
Male 17019 47.5 15201 49.6 1177 38.4 641 31.1
Female 18780 52.5 15470 50.4 1890 61.6 1420 68.9
Age group (years)
15–54 22486 62.8 21538 70.2 677 22.1 271 13.1
55–64 4490 12.5 3916 12.8 424 13.8 150 7.3
65–79 5634 15.7 4005 13.1 1097 35.8 532 25.8
≥80 3189 8.9 1212 4.0 869 28.3 1108 53.8
Survey year
1997 7926 22.1 7085 23.1 586 19.1 255 12.4
2001 9175 25.6 8130 26.5 688 22.4 357 17.3
2004 9977 27.9 8293 27.0 971 31.7 713 34.6
2008 8721 24.4 7163 23.4 822 26.8 736 35.7
Education level
Tertiary 11602 32.4 10711 34.9 615 20.1 276 13.4
Secondary 14145 39.5 12280 40.0 1194 38.9 671 32.6
Primary 5603 15.7 3737 12.2 1026 33.5 840 40.8
No diploma 512 1.4 304 1.0 105 3.4 103 5.0
No information 3937 11.0 3639 11.9 127 4.1 171 8.3
Proxy interview 3167 8.8 2339 7.6 226 7.4 602 29.2
Hospitalization rateb 2329 12.5 1521 9.8 373 20.8 435 30.2
Mobility limitationc 3797 10.6 - - 2001 65.2 1592 77.2
ADL limitationc
Transfer in/out of bed 2603 7.2 - - 1220 39.8 731 35.5
Transfer in/out of chair 2378 6.7 - - 1089 35.5 557 27.0
Dressing/undressing 2355 6.6 - - 942 30.7 864 41.9
Washing hands and face 1171 3.3 - - 255 8.3 508 24.6
Feeding 1151 3.2 - - 265 8.6 492 23.9
Using the toilet 1210 3.4 - - 251 8.2 511 24.8
aThe percentages are not weighted: they do not represent the prevalence, but the proportion in the study population
bInpatient hospitalization in the 12 months preceding the interview. Information available only for the 2004 and 2008 BHIS (N = 18,698)
cThe proportions do not add to 100 %, as an individual can have more than one ADL and/or mobility limitation
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In disabled men, chronic respiratory diseases had a
high prevalence in all age groups. For the youngest dis-
abled men (15–54 years), depression and migraine were
also among the most prevalent diseases. For instance,
the prevalence of depression in mildly disabled young
men was six times higher than in non-disabled men and
two times higher than in severely disabled men. For men
aged 55 or older, heart attack also had a high prevalence.
While the prevalence of neurological diseases was very
low in non-disabled men (<1 %) it reached 6.3 and 7.7 %
in mildly and severely disabled men, respectively.
For women aged 15–64 years, migraine and depression
were among the most frequent diseases. The prevalence
of osteoporosis and chronic respiratory diseases was also
high among women aged 55 or older. The prevalence of
stroke was low (≤2 %) in non-disabled women, reaching
2.7 and 9.5 % in mildly and severely disabled women,
respectively.
Background disability rates
The background disability rates, i.e., the disability rate
related to the causes of disability that were not included
in the analysis, are presented in Fig. 3. The background
disability rates tend to increase over age groups, with a
steep increase for severely disabled individuals aged
85 years or older. Although the background disability
rates were low for young individuals (15–54 years), the
relative contribution of background to the total disability
prevalence was high, comparable to the background con-
tribution of the oldest old (≥80 years), especially among
the severely disabled individuals (Fig. 4).
Disease-specific disability rates (disabling impacts)
The rank of the disabling impacts of the diseases (disease-
specific disability rates) is presented in Tables 4 and 5
for men and women, respectively. Overall, the disease
disability rates increased over age and were higher in
women compared to men.
In men, neurological diseases had the highest impact
on mild and severe disability in all age groups. For
mildly disabled men, osteoporosis, stroke and cancer
also had a great impact on disability, while for severely
disabled men, stroke, chronic cystitis, and osteoporosis
were among the most disabling diseases. Low disabling
impacts were observed for diabetes, chronic cystitis,
other diseases, and bowel diseases in mildly disabled
men and for bowel diseases, stomach ulcer, and other
diseases in severely disabled men (Table 4).
In women, the diseases with great impact on mild
disability were stroke, arthritis, bowel diseases, and heart
attack. In contrast, for women with severe disability,
neurological diseases, stroke, diabetes, and cancer had
the highest disabling impacts. Chronic cystitis and stom-
ach ulcer were the least disabling diseases in mildly
disabled and back pain and other diseases had a low
impact on severe disability (Table 5).
Contribution of chronic diseases and background to the
disability burden
The contribution of diseases and background to the
disability burden and the disability prevalence is presented
in Tables 6 and 7 for men and women, respectively. Al-
though disability is present in all age groups, the preva-
lence of mild and severe disability is low for the youngest
2
3
4
5
6
1997 2001 2004 2008
Year
D
is
ab
ili
ty
 p
re
va
le
nc
e 
(%
)
Disability outcome
Mild
Severe
Fig. 2 Age and gender standardized prevalence of mild and severe disability. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008
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individuals (15–54 years). The prevalence of mild disability
was higher than severe disability for individuals aged
15–79 years. However, among the oldest old (≥80 years),
different patterns were observed: no difference in the
prevalence of mild and severe disability was observed
among men, whilst in women the prevalence of severe
disability reaches substantial levels (51 %), exceeding the
prevalence of mild disability in this age group.
The relative background contribution was high for all
disability severity levels and age groups in men and
women (Fig. 4). For severely disabled individuals, more
than 50 % of the disability burden was attributed to
background in the youngest (15–54 years) and oldest
(≥80 years) individuals (Fig. 4).
Men - mild disability
For mildly disabled men aged below 65 years, low back
pain and arthritis were the main contributors to the
disability burden. These two musculoskeletal diseases
accounted for 29 and 35 % for the disability burden in
mildly disabled men aged 15–54 years and 55–64 years,
respectively (Table 6 and Fig. 4). Depression and heart
attack were also important contributors for mildly dis-
abled men aged 15–54 years and 55–64 years, respectively.
In mildly disabled men at older ages (≥65 years) arthritis,
heart attack, low back pain, and chronic respiratory dis-
eases contributed most to the disability burden. Stroke
(<3 %) and bowel diseases (<0.5 %) showed a low contri-
bution to the mild disability prevalence in men (Table 6
and Fig. 4).
Men - severe disability
In men with severe disability, chronic respiratory dis-
eases were the main contributor to the disability burden
in all age groups. Disability prevalence attributable to
chronic respiratory diseases varied from 13 % in men
Table 2 Prevalence of chronic diseases in men according to disability severity. Health Interview Survey, Belgium, 1997, 2001, 2004,
and 2008
Diseases 15–54 years 55–64 years 65–79 years ≥80 years
Not disabled Mild Severe Not disabled Mild Severe Not disabled Mild Severe Not disabled Mild Severe
n 10806 284 131 1966 177 72 1905 440 188 524 276 250
Chronic respiratory diseases 4.9 13.4 10.2 7.9 22.0 30.3 12.3 30.1 28.6 11.8 25.3 36.3
Diabetes 1.1 3.5 4.9 5.8 10.3 27.7 10.1 14.6 8.4 8.0 11.6 14.7
Cancer 0.3 2.2 0.2 1.5 4.8 4.0 4.1 6.3 6.9 2.6 8.9 4.0
Depression 3.8 22.1 9.5 4.1 8.5 11.4 3.7 7.1 18.4 3.5 3.0 8.7
Neurological diseases 0.5 5.6 7.1 0.4 1.0 7.7 0.8 6.3 4.9 0.8 6.0 6.4
Stomach ulcer 2.2 10.0 5.2 3.9 16.1 6.1 4.6 8.9 7.2 4.2 9.1 4.6
Bowel diseases 1.7 8.4 6.6 2.8 5.6 6.4 3.6 4.4 6.0 3.9 5.3 9.7
Chronic kidney diseases 1.1 2.9 1.5 1.5 3.4 8.8 2.6 5.0 4.4 1.1 4.2 1.9
Liver diseases 0.5 4.1 0.0 0.9 0.5 0.5 0.7 4.4 0.5 0.3 1.2 1.4
Gall-stones 0.2 0.9 3.1 0.5 0.4 1.7 1.0 1.8 4.1 2.4 0.5 3.3
Glaucoma 0.8 2.8 2.8 1.9 3.9 5.2 3.3 7.2 4.5 4.3 5.2 8.5
Cataract 0.1 1.2 0.0 0.7 5.0 11.7 4.9 5.8 13.1 9.1 17.0 14.0
Migraine 5.7 19.7 9.8 4.5 8.7 12.6 2.9 4.4 4.3 3.0 5.5 6.6
Thyroid problems 0.7 2.3 2.7 2.2 5.5 1.0 2.6 4.3 7.5 2.1 3.0 2.0
Chronic skin diseases 2.8 5.1 5.5 2.5 7.2 6.2 4.0 2.3 5.1 3.1 4.9 9.0
Chronic cystitis 0.3 1.1 6.9 0.9 2.9 0.6 1.9 4.3 8.6 2.2 4.4 10.0
Cardiovascular diseases
Heart attack 0.9 6.9 6.3 6.7 24.7 18.4 12.1 22.7 25.9 16.4 31.0 21.9
Stroke 0.2 1.6 3.0 0.5 2.9 9.9 1.6 1.3 8.4 3.0 7.1 9.9
Musculoskeletal diseases
Low back pain 10.2 39.6 26.2 13.6 46.1 34.1 16.2 26.4 16.5 11.6 13.2 17.0
Osteoporosis 0.2 7.1 4.3 1.6 3.0 2.1 2.2 7.8 10.1 3.8 4.1 12.7
Arthritis 6.4 23.0 14.0 20.4 42.1 38.9 24.8 41.2 45.8 22.2 45.2 48.9
n: number of individuals
Arthritis: osteoarthritis and rheumatoid arthritis; chronic respiratory diseases: asthma, chronic bronchitis, chronic obstructive pulmonary disease, emphysema;
neurological diseases: epilepsy and Parkinson’s disease
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Table 3 Prevalence of chronic diseases in women according to disability severity. Health Interview Survey, Belgium, 1997, 2001,
2004, and 2008
Diseases 15–54 years 55–64 years 65–79 years ≥80 years
Not disabled Mild Severe Not disabled Mild Severe Not disabled Mild Severe Not disabled Mild Severe
n 10732 393 140 1950 247 78 2100 657 344 688 593 858
Chronic respiratory diseases 6.0 20.7 15.4 6.9 16.0 15.2 7.9 21.3 24.4 7.9 10.5 15.1
Diabetes 1.2 5.0 3.1 4.9 12.2 14.0 8.0 12.2 18.3 5.6 8.9 11.1
Cancer 0.7 3.7 3.2 2.1 6.1 5.7 4.1 4.2 8.1 1.9 2.9 6.0
Depression 6.0 21.7 14.5 7.2 24.0 21.3 6.7 14.4 17.6 3.9 7.2 11.2
Neurological diseases 0.6 2.0 12.0 1.2 3.2 3.2 0.5 2.2 8.4 1.6 1.8 6.5
Stomach ulcer 2.2 9.5 2.7 4.3 9.8 18.0 4.3 9.7 10.1 3.4 5.7 10.7
Bowel diseases 2.4 14.1 6.9 3.7 9.3 18.7 4.7 11.0 15.2 1.8 7.4 7.7
Chronic kidney diseases 1.1 3.7 1.1 1.3 1.3 6.6 0.8 5.7 6.7 0.9 1.6 4.0
Liver diseases 0.4 1.7 1.0 0.8 1.7 2.1 1.5 2.1 2.6 0.2 1.5 2.0
Gall-stones 0.6 1.5 0.7 1.2 1.4 4.1 1.9 2.5 8.0 1.5 4.0 3.4
Glaucoma 0.6 1.0 0.7 3.1 9.0 6.1 4.9 7.5 10.0 5.4 8.8 8.3
Cataract 0.2 1.1 0.3 1.0 1.6 8.0 8.2 12.8 12.1 16.5 15.0 15.4
Migraine 15.5 29.8 24.6 10.9 26.9 25.7 7.8 13.5 18.8 5.9 5.7 9.9
Thyroid problems 4.6 11.5 7.8 8.8 9.5 10.4 9.5 12.3 14.6 4.7 10.7 12.0
Chronic skin diseases 3.4 5.7 0.4 2.9 8.2 2.9 3.2 4.9 3.8 3.2 1.5 7.5
Chronic cystitis 1.9 4.4 4.0 2.4 3.5 9.9 2.3 7.2 8.0 2.9 5.7 8.7
Cardiovascular diseases
Heart attack 0.7 4.7 0.9 2.9 7.4 8.4 7.1 14.5 15.8 7.5 13.1 20.7
Stroke 0.1 2.7 4.0 0.9 2.7 5.1 1.0 4.0 7.6 2.1 2.6 9.5
Musculoskeletal diseases
Low back pain 9.7 40.8 18.9 16.2 46.4 40.6 19.7 35.4 39.1 15.0 26.7 23.9
Osteoporosis 1.4 4.3 7.7 9.9 16.8 28.7 16.8 27.2 27.6 13.4 25.4 28.1
Arthritis 7.6 37.8 20.5 27.8 63.6 61.6 41.5 67.7 70.0 40.9 58.8 65.8
n: number of individuals
Arthritis: osteoarthritis and rheumatoid arthritis; chronic respiratory diseases: asthma, chronic bronchitis, chronic obstructive pulmonary disease, emphysema;
neurological diseases: epilepsy and Parkinson’s disease
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Fig. 3 Background disability rate by gender and age groups. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008
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aged 55–64 years to 7 % in men aged 85 and older. In
the youngest severely disabled men, low back pain,
neurological diseases, and depression were also impor-
tant contributors, while for men aged 55–79 years,
arthritis and heart attack were among the main contrib-
utors. For the oldest severely disabled men (≥80 years)
heart attack and stroke were also important contributors
to the disability burden (Table 6 and Fig. 4).
Table 4 Rank of disease-specific disability rates (disabling impacts) according to disability severity in men. Health Interview Survey,
Belgium, 1997, 2001, 2004, and 2008
Rank Mild disability
15–54 years 55–64 years 65–79 years ≥80 years
Diseases Rate 95 % CI Diseases Rate 95 % CI Diseases Rate 95 % CI Diseases Rate 95 % CI
1 Neurological
diseases
0.24 0.11;0.39 Neurological
diseases
0.49 0.22;0.88 Neurological
diseases
0.57 0.23;0.95 Neurological
diseases
0.84 0.28;1.34
2 Osteoporosis 0.14 0.06;0.25 Osteoporosis 0.28 0.14;0.54 Osteoporosis 0.33 0.15;0.58 Osteoporosis 0.48 0.18;0.77
3 Stroke 0.08 0.00;0.19 Stroke 0.16 0.00;0.42 Stroke 0.19 0.00;0.42 Stroke 0.28 0.00;0.61
4 Cancer 0.07 0.01;0.15 Cancer 0.15 0.02;0.31 Cancer 0.18 0.02;0.32 Cancer 0.26 0.03;0.45
5 Heart attack 0.07 0.04;0.12 Heart attack 0.15 0.08;0.25 Heart attack 0.17 0.09;0.25 Heart attack 0.25 0.11;0.37
6 Depression 0.05 0.03;0.09 Depression 0.11 0.06;0.20 Depression 0.13 0.06;0.21 Depression 0.19 0.07;0.31
7 Low back pain 0.05 0.04;0.07 Low back pain 0.11 0.07;0.17 Low back pain 0.12 0.07;0.18 Low back pain 0.18 0.08;0.26
8 Stomach ulcer 0.05 0.02;0.08 Stomach ulcer 0.10 0.04;0.20 Stomach ulcer 0.12 0.04;0.22 Stomach ulcer 0.17 0.05;0.31
9 Chronic
respiratory
diseases
0.04 0.02;0.06 Chronic
respiratory
diseases
0.08 0.04;0.15 Chronic
respiratory
diseases
0.10 0.04;0.16 Chronic
respiratory
diseases
0.14 0.05;0.23
10 Arthritis 0.03 0.02;0.05 Arthritis 0.07 0.05;0.11 Arthritis 0.08 0.04;0.13 Arthritis 0.12 0.05;0.20
11 Diabetes 0.01 0.00;0.04 Diabetes 0.02 0.00;0.07 Diabetes 0.03 0.00;0.09 Chronic cystitis 0.10 −0.02;0.27
12 Chronic cystitis 0.03 −0.01;0.09 Other diseasesa 0.01 0.00;0.04 Other diseasesa 0.02 0.00;0.04 Diabetes 0.04 −0.01;0.12
13 Bowel diseases 0.01 −0.01;0.04 Chronic cystitis 0.06 −0.01;0.19 Chronic cystitis 0.07 −0.01;0.20 Bowel diseases 0.02 −0.03;0.13
14 Other diseasesa 0.01 0.00;0.01 Bowel diseases 0.01 −0.02;0.09 Bowel diseases 0.01 −0.02;0.10 Other diseasesa 0.02 −0.01;0.05
Rank Severe Disability
55–64 years 55–64 years 65–79 years ≥80 years
Diseases Rate 95 % CI Diseases Rate 95 % CI Diseases Rate 95 % CI Diseases Rate 95 % CI
1 Neurological
diseases
0.12 0.05;0.21 Neurological
diseases
0.30 0.10;0.52 Neurological
diseases
0.34 0.15;0.71 Neurological
diseases
0.72 0.27;1.31
2 Stroke 0.09 0.03;0.20 Stroke 0.23 0.08;0.40 Stroke 0.26 0.13;0.49 Stroke 0.54 0.24;0.98
3 Chronic cystitis 0.07 0.00;0.20 Chronic cystitis 0.18 0.01;0.35 Chronic cystitis 0.20 0.01;0.42 Chronic cystitis 0.42 0.02;0.85
4 Osteoporosis 0.05 0.00;0.13 Osteoporosis 0.12 0.01;0.24 Osteoporosis 0.14 0.01;0.32 Osteoporosis 0.29 0.02;0.62
5 Chronic
respiratory
diseases
0.02 0.01;0.04 Chronic
respiratory
diseases
0.06 0.02;0.10 Chronic
respiratory
diseases
0.07 0.03;0.13 Chronic
respiratory
diseases
0.14 0.05;0.27
6 Depression 0.02 0.00;0.04 Heart attack 0.06 0.01;0.10 Heart attack 0.06 0.02;0.14 Heart attack 0.14 0.04;0.25
7 Heart attack 0.02 0.01;0.05 Depression 0.04 0.00;0.10 Depression 0.05 0.00;0.18 Depression 0.10 0.00;0.29
8 Diabetes 0.01 0.00;0.03 Diabetes 0.03 0.00;0.07 Diabetes 0.04 0.01;0.08 Diabetes 0.08 0.01;0.17
9 Cancer 0.01 0.00;0.03 Low back pain 0.02 0.00;0.04 Low back pain 0.03 0.01;0.05 Low back pain 0.06 0.02;0.11
10 Low back pain 0.01 0.00;0.02 Arthritis 0.02 0.00;0.03 Arthritis 0.02 0.00;0.05 Arthritis 0.04 0.00;0.10
11 Bowel diseases 0.01 0.00;0.02 Cancer 0.02 0.00;0.06 Cancer 0.02 −0.01;0.08 Cancer 0.05 −0.01;0.15
12 Arthritis 0.01 0.00;0.02 Bowel diseases 0.01 -0.01;0.05 Bowel diseases 0.02 −0.01;0.07 Bowel diseases 0.03 −0.02;0.13
13 Other diseasesa 0.00 0.00;0.01 Other diseasesa 0.00 -0.01;0.02 Other diseasesa 0.00 −0.01;0.03 Other diseasesa 0.01 −0.02;0.05
14 Stomach ulcer 0.00 −0.01;0.00 Stomach ulcer −0.01 -0.01;0.01 Stomach ulcer −0.01 −0.02;0.01 Stomach ulcer −0.02 −0.03;0.02
Arthritis: osteoarthritis and rheumatoid arthritis; chronic respiratory diseases: asthma, chronic bronchitis, chronic obstructive pulmonary disease, emphysema;
neurological diseases: epilepsy and Parkinson’s disease
aOther diseases: kidney diseases, liver diseases, gall-stones, glaucoma, cataract, thyroid problems, skin diseases, and migraine
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Table 5 Rank of disease-specific disability rates (disabling impacts) according to disability severity in women. Health Interview
Survey, Belgium, 1997, 2001, 2004, and 2008
Rank Mild disability
15–54 years 55–64 years 65–79 years ≥80 years
Diseases Rate 95 % CI Diseases Rate 95 % CI Diseases Rate 95 % CI Diseases Rate 95 % CI
1 Stroke 0.16 0.05;0.37 Stroke 0.28 0.09;0.59 Stroke 0.34 0.10;0.74 Stroke 0.50 0.14;1.02
2 Arthritis 0.08 0.05;0.11 Arthritis 0.13 0.09;0.18 Arthritis 0.16 0.12;0.22 Arthritis 0.24 0.14;0.31
3 Heart attack 0.07 0.02;0.12 Bowel diseases 0.12 0.04;0.21 Bowel diseases 0.15 0.06;0.29 Bowel diseases 0.22 0.07;0.39
4 Bowel diseases 0.07 0.03;0.13 Heart attack 0.11 0.04;0.20 Heart attack 0.14 0.05;0.24 Heart attack 0.20 0.06;0.35
5 Low back pain 0.06 0.04;0.08 Low back pain 0.10 0.06;0.15 Low back pain 0.12 0.08;0.18 Low back pain 0.18 0.09;0.26
6 Chronic
respiratory
diseases
0.05 0.03;0.07 Diabetes 0.09 0.03;0.16 Diabetes 0.11 0.03;0.20 Diabetes 0.16 0.04;0.29
7 Diabetes 0.05 0.01;0.10 Chronic
respiratory
diseases
0.08 0.04;0.13 Chronic
respiratory
diseases
0.10 0.05;0.17 Chronic
respiratory
diseases
0.15 0.07;0.24
8 Cancer 0.04 0.00;0.10 Depression 0.08 0.03;0.13 Cancer 0.09 0.01;0.20 Depression 0.14 0.05;0.23
9 Depression 0.04 0.02;0.07 Cancer 0.07 0.01;0.17 Depression 0.09 0.04;0.17 Cancer 0.13 0.01;0.28
10 Other diseasesa 0.01 0.00;0.02 Other diseasesa 0.01 0.00;0.03 Other diseasesa 0.02 0.00;0.04 Other diseasesa 0.02 0.00;0.05
11 Neurological
diseases
0.04 −0.01;0.13 Neurological
diseases
0.07 −0.02;0.23 Neurological
diseases
0.08 −0.02;0.29 Neurological
diseases
0.12 −0.03;0.38
12 Osteoporosis 0.01 −0.01;0.03 Osteoporosis 0.02 −0.02;0.05 Osteoporosis 0.02 −0.02;0.07 Osteoporosis 0.03 −0.03;0.10
13 Stomach ulcer 0.01 −0.01;0.05 Stomach ulcer 0.02 −0.02;0.08 Stomach ulcer 0.02 −0.03;0.11 Stomach ulcer 0.03 −0.04;0.14
14 Chronic cystitis −0.01 −0.01;0.03 Chronic cystitis −0.02 −0.02;0.05 Chronic cystitis −0.02 −0.03;0.06 Chronic cystitis −0.03 −0.04;0.08
Rank Severe Disability
15–54 years 55–64 years 65–79 years ≥80 years
Diseases Rate 95 % CI Diseases Rate 95 % CI Diseases Rate 95 % CI Diseases Rate 95 % CI
1 Neurological
diseases
0.12 0.04;0.27 Neurological
diseases
0.22 0.11;0.45 Neurological
diseases
0.77 0.35;1.24 Neurological
diseases
1.61 0.94;3.12
2 Stroke 0.09 0.03;0.19 Stroke 0.17 0.07;0.34 Stroke 0.59 0.25;0.89 Stroke 1.23 0.68;2.26
3 Diabetes 0.02 0.01;0.03 Diabetes 0.03 0.01;0.07 Diabetes 0.11 0.04;0.18 Diabetes 0.22 0.10;0.46
4 Cancer 0.02 0.00;0.05 Cancer 0.03 0.00;0.10 Cancer 0.10 0.00;0.26 Cancer 0.22 0.01;0.70
5 Chronic
respiratory
diseases
0.01 0.00;0.02 Chronic cystitis 0.03 0.00;0.08 Chronic cystitis 0.09 0.01;0.22 Chronic cystitis 0.19 0.03;0.57
6 Depression 0.01 0.00;0.02 Bowel diseases 0.03 0.00;0.07 Bowel diseases 0.09 0.00;0.20 Bowel diseases 0.19 0.01;0.50
7 Chronic cystitis 0.01 0.00;0.04 Arthritis 0.03 0.01;0.05 Arthritis 0.09 0.04;0.12 Stomach ulcer 0.18 0.00;0.50
8 Heart attack 0.01 0.00;0.03 Depression 0.02 0.00;0.05 Depression 0.08 0.01;0.16 Arthritis 0.18 0.10;0.35
9 Low back pain 0.01 0.00;0.02 Heart attack 0.02 0.00;0.05 Stomach ulcer 0.08 0.00;0.19 Depression 0.16 0.02;0.42
10 Osteoporosis 0.01 0.00;0.02 Osteoporosis 0.02 0.00;0.04 Heart attack 0.07 0.00;0.15 Heart attack 0.14 0.00;0.42
11 Stomach ulcer 0.01 0.00;0.03 Stomach ulcer 0.02 0.00;0.07 Chronic
respiratory
diseases
0.05 0.01;0.12 Osteoporosis 0.11 0.02;0.26
12 Bowel diseases 0.01 0.00;0.03 Chronic
respiratory
diseases
0.01 0.00;0.04 Low back pain 0.05 0.01;0.09 Chronic
respiratory
diseases
0.10 0.01;0.30
13 Arthritis 0.01 0.00;0.03 Low back pain 0.01 0.00;0.03 Osteoporosis 0.05 0.01;0.10 Low back pain 0.10 0.01;0.23
14 Other diseasesa 0.00 0.00;0.01 Other diseasesa 0.00 0.00;0.01 Other diseasesa 0.01 −0.01;0.03 Other diseasesa 0.02 −0.02;0.10
Arthritis: osteoarthritis and rheumatoid arthritis; chronic respiratory diseases: asthma, chronic bronchitis, chronic obstructive pulmonary disease, emphysema;
neurological diseases: epilepsy and Parkinson’s disease
aOther diseases: kidney diseases, liver diseases, gall-stones, glaucoma, cataract, thyroid problems, skin diseases, and migraine
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Table 6 Rank of absolute contribution of diseases and background to the prevalence of disability, according to disability severity in
men. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008
Rank Mild disability
15–54 years 55–64 years 65–79 years ≥80 years
Diseases % 95 % CI Diseases % 95 % CI Diseases % 95 % CI Diseases % 95 % CI
1 Background 0.92 0.91;0.92 Background 1.81 1.77;1.86 Background 7.86 7.57;8.17 Background 19.68 18.74;20.52
2 Low back pain 0.52 0.36;0.70 Low back pain 1.66 0.99;2.45 Arthritis 1.97 1.07;2.98 Heart attack 3.48 1.74;5.76
3 Arthritis 0.22 0.13;0.33 Arthritis 1.55 0.91;2.27 Heart attack 1.91 1.10;2.80 Arthritis 2.57 1.21;4.38
4 Depression 0.21 0.11;0.35 Heart attack 1.10 0.55;1.74 Low back pain 1.82 1.16;2.57 Chronic
respiratory
diseases
1.60 0.68;2.82
5 Chronic
respiratory
diseases
0.20 0.11;0.30 Chronic
respiratory
diseases
0.73 0.33;1.24 Chronic
respiratory
diseases
1.26 0.58;2.04 Low back pain 1.43 0.78;2.27
6 Neurological
diseases
0.13 0.06;0.22 Depression 0.47 0.22;0.79 Osteoporosis 0.77 0.32;1.38 Neurological
diseases
1.15 0.30;2.54
7 Stomach ulcer 0.11 0.04;0.19 Stomach ulcer 0.47 0.17;0.84 Neurological
diseases
0.73 0.22;1.50 Osteoporosis 1.06 0.42;1.93
8 Heart attack 0.07 0.03;0.13 Osteoporosis 0.41 0.19;0.67 Cancer 0.60 0.10;1.18 Cancer 0.74 0.10;1.58
9 Osteoporosis 0.05 0.02;0.10 Cancer 0.24 0.04;0.49 Stomach ulcer 0.50 0.19;0.87 Stomach ulcer 0.66 0.20;1.29
10 Diabetes 0.02 0.00;0.04 Neurological
diseases
0.18 0.07;0.32 Depression 0.44 0.22;0.72 Depression 0.40 0.14;0.78
11 Cancer 0.02 0.00;0.05 Stroke 0.12 0.00;0.33 Stroke 0.23 0.00;0.47 Stroke 0.82 −0.01;2.17
12 Chronic cystitis 0.01 0.00;0.03 Other diseasesa 0.18 −0.05;0.47 Diabetes 0.32 −0.05;0.78 Other diseasesa 0.33 −0.09;0.89
13 Stroke 0.01 0.00;0.03 Diabetes 0.17 −0.03;0.42 Other diseasesa 0.25 −0.07;0.66 Diabetes 0.32 −0.05;0.88
14 Bowel diseases 0.01 −0.01;0.07 Chronic cystitis 0.07 −0.01;0.17 Chronic cystitis 0.15 −0.02;0.40 Chronic cystitis 0.21 −0.04;0.61
15 Other diseasesa 0.07 −0.02;0.16 Bowel diseases 0.03 −0.05;0.24 Bowel diseases 0.04 −0.07;0.30 Bowel diseases 0.06 −0.10;0.41
- Total disability
prevalence
2.57 2.24;2.94 Total disability
prevalence
9.16 7.37;11.11 Total disability
prevalence
18.84 16.18;21.47 Total disability
prevalence
34.51 29.91;39.84
Rank Severe Disability
15–54 years 55–64 years 65–79 years ≥80 years
Diseases Diseases % 95 % CI Diseases % 95 % CI Diseases % 95 % CI
1 Background 0.64 0.64;0.64 Background 0.92 0.91;0.93 Background 3.18 3.09;3.27 Background 17.37 16.28;18.47
2 Chronic
respiratory
diseases
0.11 0.05;0.18 Chronic
respiratory
diseases
0.43 0.15;0.81 Chronic
respiratory
diseases
0.90 0.32;1.59 Chronic
respiratory
diseases
2.06 0.70;4.12
3 Low back pain 0.09 0.03;0.18 Heart attack 0.34 0.09;0.66 Heart attack 0.88 0.25;1.78 Heart attack 1.85 0.57;3.46
4 Depression 0.06 0.00;0.14 Arthritis 0.31 0.02;0.70 Arthritis 0.55 0.03;1.30 Stroke 1.63 0.65;3.01
5 Neurological
diseases
0.06 0.03;0.11 Low back pain 0.29 0.07;0.60 Stroke 0.49 0.23;0.83 Osteoporosis 1.23 0.10;2.74
6 Arthritis 0.04 0.00;0.10 Diabetes 0.19 0.02;0.45 Low back pain 0.43 0.14;0.78 Arthritis 1.00 0.06;2.35
7 Chronic cystitis 0.03 0.00;0.08 Depression 0.16 0.00;0.42 Chronic cystitis 0.38 0.03;0.82 Neurological
diseases
0.99 0.39;1.91
8 Heart attack 0.02 0.00;0.05 Stroke 0.15 0.05;0.31 Diabetes 0.36 0.05;0.70 Chronic cystitis 0.98 0.07;2.28
9 Stroke 0.02 0.00;0.04 Osteoporosis 0.15 0.01;0.31 Osteoporosis 0.35 0.03;0.82 Diabetes 0.57 0.06;1.26
10 Diabetes 0.01 0.00;0.04 Neurological
diseases
0.15 0.04;0.35 Neurological
diseases
0.33 0.12;0.57 Low back pain 0.56 0.18;1.11
11 Osteoporosis 0.01 0.00;0.03 Chronic cystitis 0.11 0.01;0.26 Depression 0.27 0.00;0.87 Depression 0.38 −0.01;1.09
12 Cancer 0.00 0.00;0.01 Cancer 0.03 −0.01;0.09 Cancer 0.10 −0.03;0.31 Bowel diseases 0.14 −0.09;0.60
13 Bowel diseases 0.01 −0.01;0.04 Bowel diseases 0.03 −0.02;0.15 Other diseasesa 0.07 −0.19;0.48 Other diseasesa 0.14 −0.34;0.94
14 Other diseasesa 0.01 −0.04;0.08 Other diseasesa 0.03 −0.10;0.22 Bowel diseases 0.06 −0.04;0.22 Cancer 0.11 −0.03;0.36
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Women - mild disability
In women with mild disability, arthritis and low back
pain were the main contributors to the disability preva-
lence in all age groups, accounting for 25–46 % of the
disability burden (Table 7 and Fig. 4). Depression and
chronic respiratory diseases were also important contri-
butors in women aged less than 65 years. Disability at-
tributed to depression varied from 8 % in women aged
15–54 years and 5 % in women aged 55–64 years. For
women aged 65 years or older, heart attack and chronic
respiratory diseases were among the main contributors
to the disability burden. Stomach ulcer, chronic cystitis,
and neurological diseases were not important contribu-
tors (Table 7 and Fig. 4).
Women - severe disability
Arthritis was the main contributor to the severe dis-
ability burden in women, accounting for 8–25 % of
the total disability prevalence. For women at young
ages (<65 years), neurological diseases, depression, and
low back pain were also important contributors. For se-
verely disabled women aged 65–79 years, low back pain
and diabetes were among the main contributors, repre-
senting 7 and 6 % of the disability burden in this age
group. In the oldest old women (≥80 years), stroke and
neurological diseases had an important contribution to
the disability burden, accounting for 6 and 5 %, respect-
ively. Cancer and chronic cystitis had a low contribution
to the severe disability prevalence in women (Table 7 and
Fig. 4).
Disability prevalence
The mild disability prevalence was higher than severe
disability prevalence for men and women in all age
groups, except in the oldest old women (≥80 years), in
which the prevalence of severe disability was 1.2 times
higher than the prevalence of mild disability.
The total mild disability prevalence was higher for
women compared to men in all age groups. For severe
disability, almost no gender difference was observed in
individuals aged <65 years, while the prevalence of se-
vere disability in women was 1.6 and 1.7 times higher
than men aged 65–79 years and 80 years or older,
respectively (Tables 6 and 7).
Discussion
A stable prevalence of mild (5 %) and severe (2–3 %) disabil-
ity was observed for the Belgian population aged 15 years or
older between 1997 and 2008. For women, arthritis was the
main contributor to the mild and severe disability burden.
For men with mild disability, low back pain, arthritis, and
heart attack contributed most to the disability burden in
men aged 15–64 years, 65–79 years, and ≥ 80 years, respect-
ively. For severely disabled men, chronic respiratory diseases
contributed most to the disability prevalence. The contribu-
tion also differed by age: for mild disability, depression and
chronic respiratory diseases were important contributors
among young individuals, while heart attack had a large con-
tribution for older individuals. For severe disability, neuro-
logical diseases and stroke presented a large contribution in
young and elderly individuals, respectively.
Disability prevalence
Different disability trends are found across countries and
time [26, 27]. Although most studies in developed countries
showed a decline in the disability prevalence [26, 28, 29], a
stable disability prevalence was found across the four BHIS,
similar to the trends in the Netherlands for activity limita-
tions from 1990 to 2008 [30]. Despite the differences in the
methodology and disability definition, the estimated preva-
lence of severe disability in Belgium was slightly higher than
the one found in France in 2008–2009, where this preva-
lence was 1.4 % [12]. The small increase observed for severe
disability in Belgium from 1997, 2001, and 2004 to 2008 can
be due to the change in the options of answer in the
ADL questions in 2008. In the BHIS from 1997 to 2004,
only three answers were possible, while in the 2008 BHIS
a fourth option – “with a lot of difficulty” – was added
and included in our definition of severe disability.
The higher prevalence of mild compared to severe disabil-
ity in all age groups indicates that difficulty is more common
than dependence, except for women aged 80 years or older,
in which more than half of the women reported dependence.
Dependence is more common among women and increases
with age [13, 31]. This gender difference can be a result of
greater longevity and comorbidity in women compared to
men [13, 31]. Another possible explanation for the gender
difference is a composition effect. Among the oldest old in-
dividuals (≥80 years) in our study, 15 % of the men and 23 %
of the women were aged 90 years or older. Since at the
Table 6 Rank of absolute contribution of diseases and background to the prevalence of disability, according to disability severity in
men. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008 (Continued)
15 Stomach ulcer 0.00 −0.01;0.01 Stomach ulcer −0.02 −0.04;0.02 Stomach ulcer −0.03 −0.09;0.03 Stomach ulcer −0.04 −0.13;0.07
- Total disability
prevalence
1.12 0.94;1.33 Total disability
prevalence
3.28 2.24;4.39 Total disability
prevalence
8.32 6.43;10.34 Total disability
prevalence
28.97 24.96;33.96
The disease contribution do not sum to the total disability prevalence due to rounding
Arthritis: osteoarthritis and rheumatoid arthritis; chronic respiratory diseases: asthma, chronic bronchitis, chronic obstructive pulmonary disease, emphysema;
neurological diseases: epilepsy and Parkinson’s disease
aOther diseases: kidney diseases, liver diseases, gall-stones, glaucoma, cataract, thyroid problems, skin diseases, and migraine
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Table 7 Rank of absolute contribution of diseases and background to the prevalence of disability, according to disability severity in
women. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008
Rank Mild disability
15–54 years 55–64 years 65–79 years ≥80 years
Diseases % 95 % CI Diseases % 95 % CI Diseases % 95 % CI Diseases % 95 % CI
1 Background 1.08 1.08;1.08 Arthritis 3.67 2.59;4.88 Background 10.55 10.23;10.85 Background 24.72 23.86;25.65
2 Arthritis 0.63 0.42;0.91 Background 2.83 2.79;2.86 Arthritis 6.44 4.69;8.36 Arthritis 7.68 4.82;10.54
3 Low back pain 0.59 0.40;0.81 Low back pain 1.73 1.01;2.63 Low back pain 2.38 1.47;3.35 Low back pain 2.37 1.26;3.64
4 Chronic
respiratory
diseases
0.30 0.16;0.45 Depression 0.61 0.25;1.05 Chronic
respiratory
diseases
0.94 0.45;1.51 Heart attack 1.26 0.40;2.39
5 Depression 0.27 0.12;0.43 Chronic
respiratory
diseases
0.57 0.29;0.89 Heart attack 0.94 0.36;1.56 Chronic
respiratory
diseases
0.89 0.43;1.57
6 Bowel diseases 0.19 0.07;0.34 Bowel diseases 0.45 0.17;0.77 Diabetes 0.80 0.24;1.40 Diabetes 0.74 0.21;1.47
7 Diabetes 0.07 0.02;0.13 Diabetes 0.44 0.13;0.82 Bowel diseases 0.73 0.24;1.43 Stroke 0.68 0.20;1.32
8 Heart attack 0.05 0.02;0.09 Heart attack 0.32 0.11;0.57 Depression 0.66 0.26;1.21 Bowel diseases 0.56 0.19;1.05
9 Cancer 0.03 0.00;0.07 Stroke 0.24 0.07;0.49 Stroke 0.43 0.12;0.92 Depression 0.47 0.17;0.90
10 Stroke 0.03 0.01;0.08 Cancer 0.17 0.02;0.40 Cancer 0.30 0.04;0.64 Cancer 0.20 0.02;0.49
11 Other
diseasesa
0.18 −0.01;0.40 Other
diseasesa
0.33 −0.03;0.78 Osteoporosis 0.33 −0.32;1.11 Osteoporosis 0.38 −0.34;1.35
12 Stomach ulcer 0.02 −0.03;0.11 Osteoporosis 0.16 −0.15;0.51 Other
diseasesa
0.47 −0.05;1.09 Other
diseasesa
0.56 −0.04;1.35
13 Neurological
diseases
0.02 −0.01;0.07 Neurological
diseases
0.08 −0.03;0.27 Stomach ulcer 0.09 −0.12;0.46 Neurological
diseases
0.13 −0.04;0.41
14 Osteoporosis 0.01 −0.01;0.05 Stomach ulcer 0.07 −0.09;0.35 Neurological
diseases
0.07 −0.02;0.22 Stomach ulcer 0.08 −0.12;0.43
15 Chronic cystitis −0.01 −0.03;0.05 Chronic cystitis −0.01 −0.06;0.10 Chronic cystitis −0.02 −0.09;0.18 Chronic cystitis −0.02 −0.14;0.26
- Total disability
prevalence
3.47 3.04;3.90 Total disability
prevalence
11.66 9.68;13.72 Total disability
prevalence
25.10 22.32;27.93 Total disability
prevalence
40.71 36.32;44.77
Rank Severe Disability
15–54 years 55–64 years 65–79 years ≥80 years
Diseases Diseases % 95 % CI Diseases % 95 % CI Diseases % 95 % CI
1 Background 0.72 0.72;0.72 Background 1.13 1.08;1.18 Arthritis 3.25 1.84;4.68 Background 26.38 24.43;28.38
2 Arthritis 0.10 0.04;0.19 Arthritis 0.76 0.35;1.28 Background 2.74 2.60;2.89 Arthritis 7.08 3.54;11.35
3 Neurological
diseases
0.08 0.02;0.21 Low back pain 0.25 0.03;0.55 Low back pain 0.87 0.11;1.73 Stroke 3.04 1.64;5.04
4 Depression 0.07 0.01;0.13 Neurological
diseases
0.25 0.09;0.47 Diabetes 0.84 0.36;1.40 Neurological
diseases
2.54 1.34;4.18
5 Low back pain 0.07 0.01;0.15 Depression 0.19 0.02;0.40 Osteoporosis 0.80 0.12;1.56 Osteoporosis 1.61 0.24;3.29
6 Chronic
respiratory
diseases
0.05 0.01;0.11 Diabetes 0.18 0.07;0.33 Neurological
diseases
0.71 0.35;1.14 Heart attack 1.45 0.00;3.38
7 Chronic cystitis 0.03 0.00;0.07 Osteoporosis 0.17 0.02;0.39 Stroke 0.66 0.32;1.05 Low back pain 1.41 0.18;2.80
8 Stomach ulcer 0.03 0.00;0.06 Stroke 0.15 0.05;0.31 Depression 0.54 0.05;1.06 Diabetes 1.37 0.50;2.39
9 Bowel diseases 0.03 0.00;0.08 Chronic
respiratory
diseases
0.13 0.01;0.29 Chronic
respiratory
diseases
0.48 0.05;1.03 Depression 0.93 0.08;2.00
10 Diabetes 0.02 0.01;0.04 Stomach ulcer 0.13 0.00;0.29 Heart attack 0.48 0.00;1.01 Stomach ulcer 0.92 0.00;2.37
11 Cancer 0.01 0.00;0.03 Bowel diseases 0.13 0.00;0.30 Bowel diseases 0.46 0.02;1.07 Chronic
respiratory
diseases
0.89 0.11;1.90
12 Heart attack 0.01 0.00;0.02 Chronic cystitis 0.09 0.01;0.20 Cancer 0.44 0.02;1.00 Chronic cystitis 0.77 0.08;1.64
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oldest ages women seem to spend more time severely
disabled then men before death [32], the higher propor-
tion of women aged 90 years or older compared to men
in this study can also result in higher severe disability
prevalence in women compared to men among the oldest
old individuals.
Although young individuals are usually perceived as
healthy [33], the mild and severe disability prevalence in
this age group indicates that attention should also be given
to the young individuals, to reduce future development
and progression of disability.
It is interesting to notice that the most common ADLs in
both mild and severe disabled individuals were lower ex-
tremity functions, such as limitations in mobility, transfer
in and out bed and chair, although dressing and undressing
difficulties are related to both lower and upper extremity
functions [6]. This finding is line with the high contribution
of arthritis observed in men and women across all age
Table 7 Rank of absolute contribution of diseases and background to the prevalence of disability, according to disability severity in
women. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008 (Continued)
13 Stroke 0.01 0.00;0.03 Cancer 0.08 0.00;0.21 Stomach ulcer 0.35 0.00;0.76 Cancer 0.72 0.02;2.16
14 Osteoporosis 0.01 0.00;0.03 Heart attack 0.07 0.00;0.17 Chronic cystitis 0.26 0.03;0.57 Bowel diseases 0.61 0.03;1.37
15 Other
diseasesa
0.04 −0.03;0.13 Other
diseasesa
0.11 −0.06;0.32 Other
diseasesa
0.36 −0.26;1.00 Other
diseasesa
0.81 −0.54;2.34
- Total disability
prevalence
1.29 1.03;1.60 Total disability
prevalence
3.80 2.67;5.03 Total disability
prevalence
13.26 11.29;15.41 Total disability
prevalence
50.51 45.45;56.07
The disease contribution do not sum to the total disability prevalence due to rounding
Arthritis: osteoarthritis and rheumatoid arthritis; chronic respiratory diseases: asthma, chronic bronchitis, chronic obstructive pulmonary disease, emphysema;
neurological diseases: epilepsy and Parkinson’s disease
aOther diseases: kidney diseases, liver diseases, gall-stones, glaucoma, cataract, thyroid problems, skin diseases, and migraine
Mild disability
Proportion of total disability (%)
Background
Other diseases
Diabetes
Cancer
Osteoporosis
Stomach ulcer
Bowel diseases
Chronic cystitis
Neurological diseases
Stroke
Heart attack
Depression
Chronic respiratory diseases
Low back pain
Arthritis
0 10 20 30 40 50 60
15−54 years
0 10 20 30 40 50 60
55−64 years
0 10 20 30 40 50 60
65−79 years
0 10 20 30 40 50 60
80+ years
Women Men
Severe disability
Proportion of total disability (%)
The cause-specific contribution across age group and gender sum to 100%. Arthritis: osteoarthritis and rheumatoid arthritis; chronic
respiratory diseases: asthma, chronic bronchitis, chronic obstructive pulmonary disease, emphysema; neurological diseases: epilepsy
and Parkinson’s disease
Background
Other diseases
Diabetes
Cancer
Osteoporosis
Stomach ulcer
Bowel diseases
Chronic cystitis
Neurological diseases
Stroke
Heart attack
Depression
Chronic respiratory diseases
Low back pain
Arthritis
0 10 20 30 40 50 60
15−54 years
0 10 20 30 40 50 60
55−64 years
0 10 20 30 40 50 60
65−79 years
0 10 20 30 40 50 60
80+ years
Women Men
Fig. 4 Relative contribution of diseases (proportion of total disability prevalence) to the prevalence of mild and severe disability. Health Interview
Survey, Belgium, 1997, 2001, 2004, and 2008
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groups, as these lower extremity limitations involves the
knee, a common site of arthritis [34, 35].
Contribution of chronic diseases to the disability burden
The contribution of chronic diseases to the disability burden
differs by gender, age, and disability severity level. Although
reporting any difficulty in performing an ADL is considered
a severe limitation, as ADLs are defined as basic tasks of
daily life required for survival [26], longitudinal studies have
shown that information on difficulty and dependence in per-
forming ADLs are complementary. Thus, if both difficulty
and dependence are assessed, they can better represent the
continuum of disability than if severity level is ignored
[36, 37]. Also, it has been demonstrated that a large propor-
tion of the elderly individuals who report ADL is not
homogenous, reinforcing the importance of assessing both,
difficulty and dependence, to better understand this hetero-
geneity [37].
The contribution of diseases to the disability burden de-
pends on the disease prevalence and the disease-specific dis-
ability rates [1, 10, 11]. For most of the main contributors,
the attribution of disability was a function of high to moder-
ate disease prevalence and low to moderate disabling impact.
For example, among severely disabled women in all age
groups, arthritis was by far the main contributor to the dis-
ability burden. The high prevalence of arthritis, reaching
70 % for women aged 65–79 years, combined with its low to
moderate disabling impact (0.01–0.18) in severely disabled
women, resulted in the identification of arthritis as the main
contributor to the disability burden in all age groups. How-
ever, the most disabling diseases are not necessarily the most
prevalent diseases [1]. For instance, stroke ranked second
among the contributors to the severe disability burden in
the oldest old women. For this group, stroke had a low
prevalence (<10 %) compared to other diseases, but a very
high disabling impact (1.23), resulting in an important
contribution.
Low back pain and arthritis are known to be important
causes of disability, especially among the elderly [8–14]. In
our study these two musculoskeletal diseases were important
contributors of mild disability in men and women and also
among severely disabled women. Similar results were found
in previous studies [8, 10–13, 15], although no distinction
between mild and severe disability was reported in most of
them, except for the study conducted in France. In the
French study [12], instead of musculoskeletal diseases, psy-
chiatric and neurological diseases had the largest contribu-
tion. A possible explanation for these differences is the
difference in the disability definition, as the French study de-
fined severe disability based exclusively on dependence on
ADL, while in our study, the option “a lot of difficulty” was
also incorporated to severe disability definition; in the defin-
ition of the disease groups, since dementia, headache, and
multiple sclerosis were included in the neurological diseases
group in the study conducted in France; and in the method-
ology, as the French study assessed the disability burden
based on the average attribution fraction [38] to estimate the
impact of diseases on disability, without stratifying the re-
sults per gender, hampering comparability.
In addition to musculoskeletal diseases, chronic respira-
tory diseases had an important contribution to the mild
disability burden among young individuals. Chronic re-
spiratory diseases have a direct effect on the development
of disability in middle-aged individuals, with a great im-
pact in the performance of lower extremity functions [39].
An interesting result is the association of depression
with both mild and severe disability in young individuals,
indicating its relation with difficulty and dependence.
Depression is one of most disabling diseases, being the
main cause of years of life lost due to disability in young
individuals worldwide [12, 33, 40].
In general, the results for mild disability were very
similar to our previous findings, using the same data
(BHIS 1997, 2001, 2004, 2008) [16], but without distin-
guishing between disability severity level. Possibly, our
previous results were driven by mild disability, since the
number of individuals with mild disability was 1.5 times
higher than that of severe disability.
Another important finding of this study was the iden-
tification of chronic respiratory diseases as the main
contributor to the severe disability burden among men
in all age groups. Although chronic respiratory diseases
have been previously related to difficulty in mobility and
in the performance of ADLs [10, 39, 41, 42] our findings
suggest that chronic respiratory diseases are also an
important cause of dependence in men. The relation of
chronic respiratory diseases with dependence in ADLs
was previously reported, and an increase with age and
disease severity was observed [43].
Despite the different methodology used to assess the dis-
ability burden, a higher disabling impact for stroke com-
pared to other diseases and an association of stroke with
severe disability was also found in other studies [12, 44–48].
In our study it was an important contributor to severe
disability in the oldest old individuals (≥80 years), suggest-
ing a possible relation of stroke with dependence in this
group.
Neurological diseases also had a high disabling impact
for individuals with severe disability and for mildly
disabled men. Additionally, neurological diseases were
important contributors to the severe disability burden in
the youngest (15–54 years) men and women and oldest
(≥80 years) women, suggesting a relation with depend-
ence in these groups. In our study, only Parkinson’s
disease and epilepsy were included in the neurological
diseases group. Parkinson’s disease [49, 50] and epilepsy
[51] have been related to severe disability [12] and loss
of autonomy. Parkinson’s disease is more common at
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older ages and, in this study, epilepsy seems to be re-
sponsible for most of the severe disability burden attrib-
uted to neurological diseases in young individuals.
Cancer was not an important contributor to the mild
and severe disability burden. This is in agreement with
previous studies [10, 12, 48]. One possible explanation
for the low contribution of cancer is the high case-
fatality rate observed in cancer patients combined with
long periods of cancer prevalence without a substantial
impact on ADLs [48].
The high background contribution observed in the
youngest (15–54 years) and oldest (≥80 years) severely dis-
abled individuals might indicate that important causes of
severe disability in these groups were not included in our
analysis, although 21 disease were initially considered in
the models. Possible causes related to dependence in these
groups are injuries, especially from road traffic accidents
[33, 52], among the youngest, and mental disorders such
as dementia [48, 53] among the elderly.
Although not assessed in this study, our attribution results
might be related with risk factors such as smoking, obesity,
and harmful alcohol use, as the diseases that contributed
most to the disability burden – musculoskeletal, respiratory,
and cardiovascular diseases – are also associated with these
modifiable risk factors [7, 54–56]. Additionally, the increas-
ing trend in the prevalence of these risk factors observed
worldwide, especially at young ages may contribute to the
disability burden [57]. While smoking is related with high
mortality [58], obesity was identified as the most important
risk factor associated with years lived with disability
compared to smoking and harmful alcohol use in a
study conducted in the Netherlands [59].
Limitations and strengths
Some limitations should be carefully considered when
interpreting the study results. Since we used cross-
sectional data, we rely on the assumption that diseases
cause disability. However, this is not necessarily true,
although it is plausible [1] according to the disablement
model proposed by Verbrugge and Jette [60]. Conse-
quently, diseases may be incorrectly attributed to disability
in cases where disability onset preceded disease onset.
Also, the use of self-reported data may have resulted in an
underestimation of the contribution of diseases, as the val-
idity of self-reported diseases differs according to the dis-
eases being studied [61]. Furthermore, the background
contribution to both mild and severe disability might be
overestimated due to lack of information of important dis-
ability causes, such as injuries and mental disorders [10].
Selection bias may also have occurred due to the low
response rates in the four BHIS and due to the exclusion
of individuals without disability or disease information
(Fig. 1). We reported previously that individuals with
missing information on disability and diseases were more
likely to be women, elderly, and with low education level
[16]. Therefore, our results might underestimate the true
disability prevalence.
Another limitation is our definition of disability, which
was based on functional and mobility limitations. Other
measures of disability, including instrumental activities
of daily living (IADL), cognitive impairments, and sen-
sory limitations, such as hearing and vision limitations,
also play an important role in the disablement process
[62]. However, this information was not considered in
our definition because these questions were not system-
atically included in all the four BHIS.
In general, proxy respondents tend to overestimate the
disability prevalence and severity when compared to
self-responders [6, 63, 64]. In our study, 8.8 % (n = 3167)
of the interviews were answered by proxies, representing
10.4 % (n = 917) of the interviews with elderly individ-
uals (≥65 years) (Table 1). Thus, an overestimation of
the contribution of diseases to the disability burden
might have occurred. However, the use of a mix of self-
reporting and proxies is recommended in large surveys,
especially those including elderly individuals [1, 64]. Our
results support the use of proxies to investigate severe
disability, as 29 % of the severely disabled individuals
had a proxy interview (Table 1).
Although the attribution method allows the attribution of
disability to more than one disease by including interaction
terms between diseases in the model [9], we did not include
interactions between diseases in our analysis, as it would
result in a computer intensive task due to the large sample
size (N = 35,799) and large number of diseases studied
(N = 21 diseases). In the mortality analysis, a longitudinal
extension of the average attribution fraction method has
been proposed to take into account the coexistence of dis-
eases in individuals [65, 66]. Both under and overestimation
of the contribution of the diseases to the disability may
have occurred in our study as a result of ignoring the
interaction between diseases, similar to what is ob-
served in the mortality analysis [65, 66].
Furthermore, the changes in the questions of some
chronic diseases over the four BHIS impacted the preva-
lence of these diseases, resulting in a reduction in the
prevalence of heart attack and increase in the prevalence
of low back pain in 2008 compared with the previous
surveys (Additional file 1). In addition to the stable mild
and severe disability prevalence over time in the four
BHIS (Fig. 2) and across age groups (Additional file 2),
the difference in the disease prevalence of some diseases
over time supports pooling the data of the four BHIS.
The use of a large sample is one of the strengths of the
study, as it allowed the assessment of the contribution of
chronic diseases to the disability burden across different
disability severity levels. The inclusion of young individuals
in this analysis is an added value of the study, as disability
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in young individuals is usually not investigated. Also, the
representativeness of the sample used in this analysis was
improved by including elderly individuals living in institu-
tions. In our study, 6.6 % (n = 583) of the elderly (≥65 years)
lived in institutions. Furthermore, the inclusion of depres-
sion in the analysis highlights the importance of assessing it
in surveys, as it was identified as an important contributor
to the mild and severe disability burden among young indi-
viduals. Another added value of this study is the attribution
of disability to chronic diseases for different disability sever-
ity levels – moderate and severe.
Conclusions
Different from several developed countries, the disability
prevalence in Belgium based on functional and mobility
limitations was stable from 1997 to 2008. The high
contribution of musculoskeletal diseases to the mild and
severe disability prevalence shows that intervention
strategies to tackle these diseases can be attractive to
reduce the disability burden, as they will have an im-
pact on both difficulty and dependence.
Furthermore, focus should be given to chronic respira-
tory diseases, stroke, and neurological diseases, as they
were among the most disabling diseases and contribu-
tors to the severe disability burden, indicating a relation
of these diseases with dependence. Attention should also
be given to depression, an important contributor to mild
and severe disability among young individuals.
Our results indicate that the attribution of disability to
chronic diseases is more informative if different levels of
disability are taken into consideration. Measures of diffi-
culty in ADL and mobility are generally used to evaluate
health care treatment effectiveness. In contrast, depend-
ence measures are used to identify demands for particular
types of long-term care needs [1, 67]. In our study the
hospitalization rate increased with disability severity level
(Table 1), confirming previous findings [36]. Besides
hospitalization, home care visits, nursing homes admis-
sion, and death also increase with disability severity level
[36]. Therefore, the identification of which diseases are
related to the different levels of disability severity can
assist policymakers in the definition of strategies to
tackle disability, involving prevention, rehabilitation pro-
grams (especially for dependence), support services, and
training for disabled individuals [7].
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